Template:Adrenocortical carcinoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 16: | Line 16: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Adrenocortical carcinoma (patient information)|Patient | [[Adrenocortical carcinoma (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
| Line 58: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Adrenocortical carcinoma epidemiology and demographics|Epidemiology | [[Adrenocortical carcinoma epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
| Line 76: | Line 76: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Adrenocortical carcinoma natural history|Natural History, Complications | [[Adrenocortical carcinoma natural history|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
| Line 88: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Adrenocortical carcinoma | [[Adrenocortical carcinoma staging|Staging]] | ||
|- | |- | ||
! | ! | ||
| Line 94: | Line 94: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Adrenocortical carcinoma | [[Adrenocortical carcinoma history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
| Line 100: | Line 100: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Adrenocortical carcinoma | [[Adrenocortical carcinoma physical examination|Physical Examination]] | ||
|- | |- | ||
! | ! | ||
| Line 106: | Line 106: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Adrenocortical carcinoma laboratory | [[Adrenocortical carcinoma laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
| Line 160: | Line 160: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Adrenocortical carcinoma surgery| | [[Adrenocortical carcinoma surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||
| Line 172: | Line 172: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Adrenocortical carcinoma | [[Adrenocortical carcinoma primary prevention|Primary prevention]] | ||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Adrenocortical carcinoma secondary prevention|Secondary prevention]] | |||
|- | |- | ||
! | ! | ||
[[Adrenocortical carcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
Latest revision as of 17:13, 3 October 2017
|
Adrenocortical carcinoma Microchapters |
|
Differentiating Adrenocortical carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Study |
|
Adrenocortical carcinoma On the Web |
|
American Roentgen Ray Society Images of Adrenocortical carcinoma |
|
Risk calculators and risk factors for Adrenocortical carcinoma |